Joan F. Hilton, ScD, MPH

Joan F. Hilton, ScD, MPH

Professor, Department of Epidemiology and Biostatistics, UCSF

Phone: (415) 514-8029 (voice)
Box 0560, UCSF
San Francisco, CA 94143-0560

View on UCSF Profiles


Spring Hill College, Mobile, BS, 1976, Biology
Tulane School of Public Health, New Orleans, MPH, 1982, Epidemiology
Harvard School of Public Health, Boston, MS, 1987, Biostatistics
Harvard School of Public Health, Boston, ScD, 1990, Biostatistics

Professional Experience

  • 1977-80
    University of South Alabama, Dept of Microbiology/Immunology, Research Technician
  • 1981
    Tulane University, Dept of International Health, Field Epidemiologist
  • 1982-83
    Mayo Clinic, Dept of Epidemiology, Diethylstilbestrol-Adenosis (DESAD) Project, Epidemiologist-Coordinator
  • 1983-85
    Mayo Clinic, Mayo Dept. of Oncology, Biostatistician
  • 1986
    Dana-Farber Cancer Institute, Eastern Cooperative Oncology Group, Biostatistician
  • 1987
    Massachusetts General Hospital, Dept of Surgery, Biostatistician
  • 1987-89
    Harvard School of Public Health, Dept of Biostatistics, Teaching Fellow
  • 1990-92
    Adjunct Assistant Professor of Biostatistics, UCSF Dept of Epidemiology & Biostatistics
  • 1992-97
    Assistant Professor of Biostatistics, UCSF Dept of Epidemiology & Biostatistics
  • 1997-2006
    Associate Professor of Biostatistics, UCSF Dept of Epidemiology & Biostatistics
  • 2006-present
    Professor of Biostatistics, UCSF Dept of Epidemiology & Biostatistics

Honors & Awards

  • 1976
    Most Outstanding Senior Woman, Spring Hill College
  • 1980-82
    U.S. Public Health Service Training Grants
  • 1985-88
    National Cancer Institute Training Grants
  • 1990
    International Biometric Society, ENAR: Student Research Award
  • 1997
    President, International Biometric Society, Western North American Region
  • 2000
    Local Organizing Chair, International Biometric Conference
  • 2008-2011
    Secretary, AAAS Section on Statistics
  • 2009-2010
    Fulbright Scholar Award

Selected Publications

  1. Smith-McCune K, Chen JC, Greenblatt RM, Shanmugasundaram U, Shacklett BL, Hilton JF, Johnson B, Irwin JC, Giudice LC. Unexpected Inflammatory Effects of Intravaginal Gels (Universal Placebo Gel and Nonoxynol-9) on the Upper Female Reproductive Tract: A Randomized Crossover Study. PLoS One. 2015; 10(7):e0129769.
    View on PubMed
  2. DuBois SG, Allen S, Bent M, Hilton JF, Hollinger F, Hawkins R, Courtier J, Mosse YP, Matthay KK. Phase I/II study of (131)I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma. Br J Cancer. 2015 Feb 17; 112(4):644-9.
    View on PubMed
  3. Christopoulos KA, Riley ED, Tulsky J, Carrico AW, Moskowitz JT, Wilson L, Coffin LS, Falahati V, Akerley J, Hilton JF. A text messaging intervention to improve retention in care and virologic suppression in a U.S. urban safety-net HIV clinic: study protocol for the Connect4Care (C4C) randomized controlled trial. BMC Infect Dis. 2014; 14(1):718.
    View on PubMed
  4. Satterfield JM, Bereknyei S, Hilton JF, Bogetz AL, Blankenburg R, Buckelew SM, Chen HC, Monash B, Ramos JS, Rennke S, Braddock CH. The prevalence of social and behavioral topics and related educational opportunities during attending rounds. Acad Med. 2014 Nov; 89(11):1548-57.
    View on PubMed
  5. Razani N, Hilton JF, Halpern-Felsher BL, Okumura MJ, Morrell HE, Yen IH. Neighborhood Characteristics and ADHD: Results of a National Study. J Atten Disord. 2015 Sep; 19(9):731-40.
    View on PubMed
  6. Chan JK, Kiet TK, Blansit K, Ramasubbaiah R, Hilton JF, Kapp DS, Matei D. MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer. Gynecol Oncol. 2014 Jun; 133(3):568-74.
    View on PubMed
  7. Glass AS, Hilton JF, Cowan JE, Washington SL, Carroll PR. Serial prostate biopsy and risk of lower urinary tract symptoms: results from a large, single-institution active surveillance cohort. Urology. 2014 Jan; 83(1):33-8.
    View on PubMed
  8. Hilton JF, Tu D, Seymour L, Shepherd FA, Bradbury PA. An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib. Lung Cancer. 2013 Oct; 82(1):136-42.
    View on PubMed
  9. Hyman RW, Fukushima M, Jiang H, Fung E, Rand L, Johnson B, Vo KC, Caughey AB, Hilton JF, Davis RW, Giudice LC. Diversity of the vaginal microbiome correlates with preterm birth. Reprod Sci. 2014 Jan; 21(1):32-40.
    View on PubMed
  10. Su F, Hilton JF, Nardo L, Wu S, Liang F, Link TM, Ma CB, Li X. Cartilage morphology and T1? and T2 quantification in ACL-reconstructed knees: a 2-year follow-up. Osteoarthritis Cartilage. 2013 Aug; 21(8):1058-67.
    View on PubMed
  11. Prochaska JJ, Hilton JF. Varenicline's adverse events. Choice of summary statistics: relative and absolute measures. BMJ. 2013; 346:f1092.
    View on PubMed
  12. Okumura MJ, Hersh AO, Hilton JF, Lotstein DS. Change in health status and access to care in young adults with special health care needs: results from the 2007 national survey of adult transition and health. J Adolesc Health. 2013 Apr; 52(4):413-8.
    View on PubMed
  13. Hilton JF, Blaschko SD, Whitson JM, Cowan JE, Carroll PR. The impact of serial prostate biopsies on sexual function in men on active surveillance for prostate cancer. J Urol. 2012 Oct; 188(4):1252-8.
    View on PubMed
  14. Mishina H, Hilton JF, Takayama JI. Trends and variations in infant mortality among 47 prefectures in Japan. J Eval Clin Pract. 2013 Oct; 19(5):849-54.
    View on PubMed
  15. Prochaska JJ, Hilton JF. Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis. BMJ. 2012; 344:e2856.
    View on PubMed
  16. Burman NJ, Cabana MD, Maselli JH, Hilton JF, Patel AI. Missing documentation of weight and height at preventive visits for children. Clin Pediatr (Phila). 2012 Oct; 51(10):933-8.
    View on PubMed
  17. Hilton JF, Barkoff L, Chang O, Halperin L, Ratanawongsa N, Sarkar U, Leykin Y, Muñoz RF, Thom DH, Kahn JS. A cross-sectional study of barriers to personal health record use among patients attending a safety-net clinic. PLoS One. 2012; 7(2):e31888.
    View on PubMed
  18. Vickers MM, Powell ED, Asmis TR, Jonker DJ, Hilton JF, O'Callaghan CJ, Tu D, Parulekar W, Moore MJ. Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo. Eur J Cancer. 2012 Jul; 48(10):1434-42.
    View on PubMed
  19. Houtrow AJ, Okumura MJ, Hilton JF, Rehm RS. Profiling health and health-related services for children with special health care needs with and without disabilities. Acad Pediatr. 2011 Nov-Dec; 11(6):508-16.
    View on PubMed
  20. Cooperberg MR, Hilton JF, Carroll PR. The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer. 2011 Nov 15; 117(22):5039-46.
    View on PubMed

Go to UCSF Profiles, powered by CTSI